BOMRA PRESS RELEASE on Unregistered Products
The Botswana Medicines Regulatory Authority (BoMRA) is concerned about the continued presence, increased reporting and occasional confiscation of the following unregistered products in the Botswana Market.
Unapproved Use of Ivermectin Press Release
Veterinary Ivermectin is used for control of parasites in animals and has not been approved for use in humans for Covid 19 as there has not been any research presented to the National Regulatory Authorities to demonstrate the effectiveness of the product for the condition. The use of any medical product for indications that have […]
BoMRA Press Release Listing of Medical Devices
Botswana Medicines Regulatory Authority (BoMRA) is calling on ALL STAKEHOLDERS OF MEDICAL DEVICES in Botswana to list their medical devices and In-Vitro Diagnostics (IVDs) devices with the Authority.
Press Release – unlicensed products
This serves to inform the general public that the sale, promotion and distribution of any medical products, medical devices & cosmetics in Botswana are governed by the Medicines and Related Substances Act of 2013 (MRSA). This Act led to the establishment of Botswana Medicines Authority (BOMRA), a statutory body under the Ministry of Health and […]
BoMRA Press Release Stakeholder Engagement November
BoMRA will conduct stakeholder sessions to discuss the regulatory requirements for medical devices.
BoMRA Press Release DPER Stakeholder engagements (October)
The Department of Product Evaluation & Registration at BoMRA will conduct stakeholder sessions to discuss the registration requirements for medical devices, veterinary medicines, human medicines and exemption from registration of human medicines.
Covid -19 BoMRA Office Notice
Expression of interest (Calibration of Infrared Thermometers)
The Botswana Medicines Regulatory Authority (BoMRA) is responsible for regulating the supply chain of human and veterinary medicines, medical devices and cosmetics to ensure their safety, quality and efficacy. BoMRA intends to provide recognition to calibration service providers for medical infrared thermometers. Temperature screening of members of the public using infrared thermometers has become a […]
Suspension Of Registration of GrandPa Products
The public, healthcare practitioners, importers and distributors are informed that registrations of Grand-Pa Headache products (Powder and tablets) have been suspended from the Botswana market with immediate effect. This follows a decision by the Market Authorization Holder GlaxoSmithKline CH South Africa to temporarily halt the supply of these products to Botswana and other markets. This […]
Call for Registration of medical devices distributors
Botswana Medicines Regulatory Authority (BoMRA) is calling on all entities trading in medical devices to register with the Authority.